CLINICAL_TRIALS
trial_result
· 2015-09-17
Clinical Trial Update: Dasatinib in Treating Patients With Stage IV Pancreatic Cancer [Phase 2]
Summary
A Phase 2 trial of dasatinib in patients with stage IV pancreatic cancer was terminated and results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: City of Hope Medical Center | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-09-17